EU9-16940-21327
4 vaccinations
2 coded responses
40 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 902 / CA
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
- 2020-12-23
- 2020-12-24
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
-
2020-12-30
Survey response — day 7, dose 1MedDRA: Lymphadenopathy, Medical counselling — Feeling: GoodFree text: I was vaccinated 12/23. On 12/28, I went in for my annual routine screening mammogram. I was notified that there are prominent L axillary nodes and that additional imaging is recommended. The nodes are on the same side as the vaccine administration. I just wanted to inform you of this situation. It is probably not unusual. I have been in communication with my physician and I will probably have an axillary ultrasound about 6 weeks after the second vaccine administration.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-06
-
2021-01-13
Dose 2 — Pfizer-BioNTech
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-18
- 2021-01-20
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-04-14
- 2021-07-14
-
2021-09-25
Dose 3 — Pfizer-BioNTech
- 2021-09-28
- 2021-09-29
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-11-06
- 2021-12-25
- 2022-03-26
-
2022-04-06
Dose 4 — Pfizer-BioNTech
- 2022-04-14
- 2022-04-20
- 2022-04-27
- 2022-05-05
- 2022-05-11
- 2022-05-18
-
2022-07-06
Survey response — 3 months, dose 4MedDRA: COVID-19, Patient isolation, SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activitiesFree text: I contracted COVID with positive test on May 30 although symptoms may have started on May 26. I was on a cruise at the time and isolated in my stateroom. Symptoms were extremely mild.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech | |
| 3 | 2021-09-25 | Pfizer-BioNTech | No |
| 4 | 2022-04-06 | Pfizer-BioNTech | No |
Free text
Release 1 — day 7, dose 1
Systemic reaction (other): I was vaccinated 12/23. On 12/28, I went in for my annual routine screening mammogram. I was notified that there are prominent L axillary nodes and that additional imaging is recommended. The nodes are on the same side as the vaccine administration. I just wanted to inform you of this situation. It is probably not unusual. I have been in communication with my physician and I will probably have an axillary ultrasound about 6 weeks after the second vaccine administration.
Release 12 — 3 months, dose 4
Symptoms: I contracted COVID with positive test on May 30 although symptoms may have started on May 26. I was on a cruise at the time and isolated in my stateroom. Symptoms were extremely mild.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Patient isolation | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Medical counselling | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release